Gautier Paux

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Finite Element Analysis

Epidermal Growth Factor Receptor

Metastatic Breast Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Therapeutic innovation & regulatory science

Journal of the National Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Publications

Javier Cortes, Sara Alsterlind Hurvitz, Joyce O'Shaughnessy, Suzette Delaloge, Hiroji Iwata, Hope S Rugo, Patrick Neven, Dheepak Kanagavel, Patrick Cohen, Gautier Paux, Sylvaine Cartot-Cotton, Maya Stefanova-Urena, Laure Deyme, Jihane Aouni, Bernard Sebastien, Aditya Bardia
Randomized Phase III Study of Amcenestrant Plus Palbociclib Versus Letrozole Plus Palbociclib in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Primary Results From AMEERA-5. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Javier Cortes, Sara Alsterlind Hurvitz, Joyce O'Shaughnessy, Suzette Delaloge, Hiroji Iwata, Hope S Rugo, Patrick Neven, Dheepak Kanagavel, Patrick Cohen, Gautier Paux, Sylvaine Cartot-Cotton, Maya Stefanova-Urena, Laure Deyme, Jihane Aouni, Bernard Sebastien, Aditya Bardia
Randomized Phase III Study of Amcenestrant Plus Palbociclib Versus Letrozole Plus Palbociclib in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Primary Results From AMEERA-5. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (22) (2024)
Yingwen Dong, Gautier Paux, Kristine Broglio, Freda Cooner, Guozhi Gao, Wei He, Lei Gao, Xiaoqiang Xue, Philip He
Use of Seamless Study Designs in Oncology Clinical Development- A Survey Conducted by IDSWG Oncology Sub-team. Therapeutic innovation & regulatory science 58 (5) (2024)
Yingwen Dong, Gautier Paux, Kristine Broglio, Freda Cooner, Guozhi Gao, Wei He, Lei Gao, Xiaoqiang Xue, Philip He
Use of Seamless Study Designs in Oncology Clinical Development- A Survey Conducted by IDSWG Oncology Sub-team. Therapeutic innovation & regulatory science (2024)
Sara M Tolaney, Elisabeth De Kermadec, Patrick Cohen, Gautier Paux, Lei Wang, Seock-Ah Im
Reply to Y. Yoshitomi et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Sara M Tolaney, Arlene Chan, Katarina Petrakova, Suzette Delaloge, Mario Campone, Hiroji Iwata, Parvin F Peddi, Peter A Kaufman, Elisabeth De Kermadec, Qianying Liu, Patrick Cohen, Gautier Paux, Lei Wang, Nils Ternès, Eric Boitier, Seock-Ah Im
AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Félix Balazard, Aurélie Bertaut, Élise Bordet, Stéphane Mulard, Julie Blanc, Nathalie Briot, Gautier Paux, Asma Dhaini Merimeche, Olivier Rigal, Charles Coutant, Marion Fournier, Christelle Jouannaud, Patrick Soulie, Florence Lerebours, Paul-Henri Cottu, Olivier Trédan, Laurence Vanlemmens, Christelle Levy, Marie-Ange Mouret-Reynier, Mario Campone, Keri J S Brady, Medha Sasane, Megan Rice, Catherine Coulouvrat, Anne-Laure Martin, Alexandra Jacquet, Ines Vaz Luis, Christina Herold, Barbara Pistilli
Adjuvant endocrine therapy uptake, toxicity, quality of life, and prediction of early discontinuation. Journal of the National Cancer Institute (2023)